XTN State Street SPDR S&P Transportation ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| CAR | 4.25% |
| RXO | 3.01% |
| DAL | 2.90% |
| LSTR | 2.75% |
| ARCB | 2.74% |
| MATX | 2.71% |
| KEX | 2.70% |
| R | 2.69% |
| ODFL | 2.68% |
| SNDR | 2.67% |
ETF Analysis
Fund Overview
State Street SPDR S&P Transportation ETF (XTN) currently reports 43 stock positions (subject to change), placing it in the balanced in breadth range by holdings breadth. The top line-up is CAR (4.25%), RXO (3.01%), DAL (2.90%), with CAR as the largest single weight at 4.25%. Together, the top three holdings account for 10.16%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.
Profitability & Capital Efficiency
On the question of capital productivity, ROIC is 7.63%, WACC is 9.02%, and the economic spread is -1.39%. On balance, the spread between returns and funding costs is negative — a dynamic that pressures intrinsic value unless operating performance improves. Supporting metrics show ROE at 12.66% and ROA at 3.45%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that likely needs operating improvement before returns quality can be considered durable.
Valuation
From a market pricing perspective, trailing P/E of 16.72, forward P/E of 11.36, PEG of 1.96. A modest gap between trailing and forward multiples implies the market is pricing incremental earnings improvement rather than a step-change in profitability. On a growth-adjusted basis, valuation appears reasonable relative to expected growth. The portfolio carries an aggregate current ratio of 1.55, consistent with adequate near-term liquidity management. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.
Margins & Cash Generation
The margin stack reads as follows: gross margin sits at 25.14%, operating margin at 8.31%, and free cash flow margin at 7.63%. Gross margins are in the moderate range, typical of sectors where direct costs consume a larger share of revenue. The portfolio's operating margins leave limited room between gross profit and operating earnings — a sign of cost pressure. FCF margins are in a reasonable range, though there is room for improvement in how efficiently revenues convert to free cash. The margin profile is a mixed read — some holdings are clearly well-run, but the aggregate numbers point to a basket that is not uniformly high-quality.
Growth & Forward Outlook
Where growth and expectations intersect, the estimated 12-month price change of 12.65%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 22.20% suggesting the portfolio's businesses are collectively capturing meaningful market share or pricing power. The projected 12-month EPS growth rate of 47.2% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. Both signals are useful lenses, but they tend to diverge most sharply near inflection points in both business fundamentals and market sentiment. The durability of both the operating trend and analyst optimism will determine whether the current setup translates into measurable near-term returns. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyThe overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.
This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.